Silverback Therapeutics shares owned by Vanguard Group
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Silverback Therapeutics by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $12M | 2.1M | 5.48 |
| 2023-09-30 | $8.0M | 2.1M | 3.78 |
| 2023-06-30 | $12M | 1.8M | 6.70 |
| 2023-03-31 | $11M | 1.7M | 6.51 |
| 2022-12-31 | $14M | 1.7M | 8.53 |
| 2022-06-30 | $4.5M | 1.1M | 4.24 |
| 2022-03-31 | $2.9M | 823k | 3.51 |
| 2021-09-30 | $17M | 1.7M | 9.98 |
| 2021-06-30 | $31M | 996k | 30.91 |
| 2021-03-31 | $47M | 1.1M | 43.63 |
| 2020-12-31 | $2.3M | 50k | 46.09 |